¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"eosinophilic panniculitis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic myelocyte
    È£»ê°ñ¼ö¼¼Æ÷
  • eosinophilic pneumonia
    È£»ê±¸Æó·Å
  • eosinophilic process
    È£»êµ¹±â
  • eosinophilic pustular folliculitis
    È£»ê±¸Áõ°¡°í¸§¹°ÁýÅÐÁý¿°, È£»ê±¸Áõ°¡³óÆ÷¸ð³¶¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic leukemoid reaction
    È£»ê±¸¹éÇ÷º´¸ð¾ç¹ÝÀÀ
  • eosinophilic pustular folliculitis
    È£»ê±¸ÀÜ°í¸§ÁýÅÐÁý¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eosinophilic leukemoid reaction
    È£»ê±¸¼º ¹éÇ÷º´¾ç¹ÝÀÀ
  • eosinophilic leukocyte
    È£»ê¼º¹éÇ÷±¸
  • eosinophilic leukocytosis
    È£»ê±¸¼º ¹éÇ÷±¸Áõ°¡Áõ(¡­ÛÜúìϹñòÊ¥ñø)
  • eosinophilic lymphofolliculosis
    È£»ê±¸¼º ¸²ÇÁ ¸ð³¶Áõ
  • eosinophilic meningoencephalitis
    È£»ê±¸¼º ³ú¸·¿°
  • eosinophilic myelocyte
    »êÈ£¼º °ñ¼ö¼¼Æ÷.[ÀÇ]È£»ê±¸¼º °ñ¼ö¼¼Æ÷.
  • eosinophilic pneumonia
    È£»ê±¸¼º Æó·Å.
  • eosinophilic polyp
    È£»ê±¸¿ë
  • eosinophilic pustular folliculitis
    È£»ê±¸¼º ³óÆ÷¼º ¸ð³¶¿°
  • eosinophilic spongiosis
    È£»ê±¸¼º ÇØ¸éÈ­
  • gastritis,eosinophilic
    È£»ê±¸¼º À§¿°
  • alpha antitrypsin deficiency panniculitis
    ¾ËÆÄ Çׯ®¸³½Å°áÇÌÁö¹æÃþ¿°
  • cold panniculitis
    ÇÑ·© Áö¹æÃþ¿°(ò·Û¸öµæú)
  • connective tissue panniculitis
    °áÇÕÁ¶Á÷ Áö¹æÃþ¿°
  • factitial panniculitis
    Àΰø Áö¹æÃþ¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ECFA, ECF-A eosinophilic chemotactic factor of anaphylaxis
ECFC eosinophilic chemotactic factor complement
ECI electrocerebral inactivity; eosinophilic cytoplasmic inclusions; extracorporeal irradiation
EF ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e...
EG enteroglucagon; eosinophilic granuloma; esophagogastrectomy; ethylene glycol; external genitalia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
EF Eosinophilic fasciitis
EG Eosinophilic granuloma
EPF Eosinophilic pustular folliculitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • eosinophilic spongiosis
    È£»ê±¸¼º ÇØ¸éÈ­
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
eosinophilic gastroenteritis <radiology> Eosinophilic infiltration of mucosa, submucosa, and muscularis of small bowel with or without stomach, stomach (almost always limited to antrum): enlarged gastric rugae, cobblestone nodules, polyps (=mucosal type), rigid wall with narrowed antrum/pylorus, bulky inramural mass up to 9 cm (=muscular type), wet stomach, ulcers rare, may have ascites, small bowel (predominantly jejunum), thickening and distortion of folds (=mucosal type), effacement of mucosa and narrowing of lumen (=muscular type), prognosis: tendency to spontaneous remission, treatment: steroids; removal of sensitizing agent
(12 Dec 1998)
eosinophilic granuloma <oncology, tumour> An immunologic disorder of unknown cause where there is proliferation of histiocytes (a type of cell in the immune system) in the bloodstream. The disorder is characterised by inflammation of the bronchioles and small pulmonary vessels that leads to fibrosis and destruction of alveolar cell walls. Cigarette smoking is considered a risk factor. Individuals with this disorder are also at increased risk for spontaneous pneumothorax.
Symptoms include cough, chest pains, shortness of breath, fever, weight loss and malaise. Bronchoscopy with biopsy confirms the diagnosis. Childhood forms exist and cause more systemic symptoms and findings such as failure to thrive, weight loss, fevers, irritability, rash and bone pains. Treatment is with corticosteroids.
(27 Sep 1997)
eosinophilic leukaemia Eosinophilocytic leukaemia, a form of granulocytic leukaemia in which there are conspicuous numbers of eosinophilic granulocytes in the tissues and circulating blood, or in which such cells are predominant; in chronic disease of this type, the total white blood cell count may be as high as 200,000 to 250,000 per cu mm, with as many as 80 or 90% being eosinophils, chiefly adult forms.
(05 Mar 2000)
eosinophilic leukocyte A polymorphonuclear leukocyte characterised by many large or prominent, refractile, cytoplasmic granules that are fairly uniform in size and bright yellow-red or orange when treated with Wright's or similar stains; the nuclei are usually larger than those of neutrophils, do not stain as deeply, and characteristically have two lobes (a third lobe is sometimes interposed on the connecting strand of chromatin); these leukocyte's are motile phagocytes with distinctive antiparasitic functions.
Synonym: acidophilic leukocyte, eosinocyte, eosinophil, eosinophile, oxyphil, oxyphile, oxyphilic leukocyte.
(05 Mar 2000)
eosinophilic leukocytosis A form of relative leukocytosis in which the greatest proportionate increase is in the eosinophils.
Synonym: eosinophilia.
(05 Mar 2000)
eosinophilic leukopenia A decrease in the number of eosinophilic granulocytes normally present in the circulating blood.
(05 Mar 2000)
eosinophilic lung disease <radiology> Idiopathic: Loeffler pneumonia, chronic eosinophilic pneumonia, hypereosinophilic syndrome, specific: drugs (e.g., nitrofurantoin), parasites, fungi (ABPA, bronchocentric granulomatosis), vasculitis / granulomatosis: Wegener's granulomatosis, polyarteritis nodosa, sarcoidal angiitis
(12 Dec 1998)
eosinophilic meningitis Infection of animals and man with nematodes of the genus Angiostrongylus.
Synonym: eosinophilic meningitis.
(05 Mar 2000)
eosinophilic meningoencephalitis A disease caused by infection with the rat lungworm, Angiostrongylus cantonensis, whose larvae, ingested with infected slugs or land snails (or some unidentified transport host), migrate from intestine to the meninges of the brain where the disease is produced; it is usually mild, of short duration, and characterised by fever, eosinophilia, and white blood cells (rarely nematode larvae) in the spinal fluid.
(05 Mar 2000)
eosinophilic pneumonia A self-limiting inflammation in the lungs where there is associated infiltration of eosinophils into lung tissue. Chest X-ray reveals pulmonary infiltrates and full blood count (CBC) shows increased numbers of eosinophils. The cause is unknown and the disease often resolves without treatment. Some forms may be treated with oral corticosteroids. Complications include restrictive cardiomyopathy due to fibrosis of the lining of the heart.
(27 Sep 1997)
eosinophilic pneumonopathy A self-limiting inflammation in the lungs where there is associated infiltration of eosinophils into lung tissue. Chest X-ray reveals pulmonary infiltrates and full blood count (CBC) shows increased numbers of eosinophils. The cause is unknown and the disease often resolves without treatment. Some forms may be treated with oral corticosteroids. Complications include restrictive cardiomyopathy due to fibrosis of the lining of the heart.
(27 Sep 1997)
eosinophilic pustular folliculitis A dermatosis characterised by sterile pruritic papules and pustules that coalesce to form plaques with papulovesicular borders; spontaneous exacerbations and remissions may be accompanied by peripheral leukocytosis, eosinophilia, or both, and may result in eventual destruction of hair follicles and formation of eosinophilic abscesses. The disease has been reported in AIDS, and a possibly separate form of eosinophilic pustular folliculitis occurs in infants.
Synonym: Ofuji's disease.
(05 Mar 2000)
fasciitis, eosinophilic A disease which leads to inflammation and thickening of the skin and fascia. (The fascia is a lining tissue under the skin that covers a surface of underlying tissues. When the fascia is inflamed, the condition is referred to as fasciitis. ) In eosinophilic fasciitis, the involved fascia is inflamed with the eosinophil white blood cells. There is progressive thickening, and often redness and warmth, and hardness of the skin surface.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á